참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Water | HCID 962 | — |
| 반응물 | Sodium Azide | HCID 33557 | — |
| 반응물 | Sodium Bicarbonate | HCID 516892 | — |
| 반응물 | tert-Butyl 4-bromopiperidine-1-carboxylate | HCID 15541517 | — |
| 촉매 | Sodium Iodide | HCID 5238 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 생성물 | 1,1-Dimethylethyl 4-azido-1-piperidinecarboxylate | HCID 11458794 | 100.2% |
반응 단계
To a solution of 45.3 g (172 mmol) of 4-bromo-1-(tert-butoxycarbonyl)piperidine in 750 mL of DMF was added 22.3 g (343 mmol) of sodium azide and 2.5 g (17 mmol) of sodium iodide. The reaction was stirred at RT for 24 h and then at 60° C. for 4 h. The mixture was poured into water containing 20 mL of sodium bicarbonate and extracted twice with 1:1 ether/hexane. The organic layers were each washed with a portion of water and brine, dried over sodium sulfate, combined and concentrated. The residue was purified by flash column chromatography, eluting with 5-10% ethyl acetate in hexane, to afford 39 g of title compound having a trace of elimination byproduct. 1H NMR (400 MHz, CDCl3): δ 3.78 (m, 2H), 3.55 (m, 1H), 3.07 (m, 2H), 1.85 (m, 2H), 1.52 (m, 2H), 1.43 (s, 9H).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US06140349 |
|---|
| 출처 데이터셋 | uspto-grants-2000_10 |
|---|
| ORD ID | ord-5d1170d8c5934c1dba6fb9f33ddcb659 |
|---|
| 출처 메모 | uspto-grants-2000_10 |
|---|